isoborneol has been researched along with ginsenoside rg1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XM; Sun, WD; Zhang, LJ; Zhu, JB | 1 |
| Jia, LJ; Li, JP; Liu, SL; Shi, LY; Wang, H; Xie, BP; Zhang, J | 1 |
| Guan, Q; Liu, T; Lv, L; Wang, X; Yu, S | 1 |
3 other study(ies) available for isoborneol and ginsenoside rg1
| Article | Year |
|---|---|
[Effect of absorption enhancers on nasal ginsenoside Rg1 delivery and its nasal ciliotoxicity].
Topics: Absorption; Administration, Intranasal; Animals; Bufo bufo; Camphanes; Chitosan; Cilia; Deoxycholic Acid; Drug Synergism; Female; Ginsenosides; Male; Mice; Mice, Inbred ICR; Nasal Mucosa; Rabbits; Rats; Rats, Sprague-Dawley | 2006 |
The effects of borneol on the pharmacokinetics and brain distribution of tanshinone IIA, salvianolic acid B and ginsenoside Rg
Topics: Abietanes; Animals; Benzofurans; Brain; Camphanes; Chromatography, Liquid; Drugs, Chinese Herbal; Ginsenosides; Male; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2021 |
Borneol-modified PEGylated graphene oxide as a nanocarrier for brain-targeted delivery of ginsenoside Rg1 against depression.
Topics: Animals; Brain; Depression; Humans; Polyethylene Glycols; Rats; Tissue Distribution | 2023 |